Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: implications for development of immunotherapy

Neuro-oncology
Nicole A P LiebermanCourtney A Crane

Abstract

Diffuse intrinsic pontine glioma (DIPG) is a uniformly fatal CNS tumor diagnosed in 300 American children per year. Radiation is the only effective treatment and extends overall survival to a median of 11 months. Due to its location in the brainstem, DIPG cannot be surgically resected. Immunotherapy has the ability to target tumor cells specifically; however, little is known about the tumor microenvironment in DIPGs. We sought to characterize infiltrating immune cells and immunosuppressive factor expression in pediatric low- and high-grade gliomas and DIPG. Tumor microarrays were stained for infiltrating immune cells. RNA was isolated from snap-frozen tumor tissue and Nanostring analysis performed. DIPG and glioblastoma cells were co-cultured with healthy donor macrophages, T cells, or natural killer (NK) cells, and flow cytometry and cytotoxicity assays performed to characterize the phenotype and function, respectively, of the immune cells. DIPG tumors do not have increased macrophage or T-cell infiltration relative to nontumor control, nor do they overexpress immunosuppressive factors such as programmed death ligand 1 and/or transforming growth factor β1. H3.3-K27M DIPG cells do not repolarize macrophages, but are not effecti...Continue Reading

References

Jun 21, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Fabrizio GiulianiV Wee Yong
Apr 23, 2009·Cancer Research·Hiroyuki FujisakiDario Campana
May 19, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Barbara S PaughSuzanne J Baker
Mar 4, 2011·Proceedings of the National Academy of Sciences of the United States of America·Michelle MonjePhilip A Beachy
Oct 1, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Andrea M GriesingerNicholas K Foreman
Oct 15, 2013·Cell·Cameron W BrennanUNKNOWN TCGA Research Network
Dec 18, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Cristina MaccalliGiorgio Parmiani
Apr 12, 2014·Acta Neuropathologica·Rainer Glass, Michael Synowitz
May 6, 2015·Nature Medicine·Catherine S GrassoMichelle Monje
Jun 2, 2015·The New England Journal of Medicine·Dung T LeLuis A Diaz
Sep 25, 2015·Current Opinion in Neurology·Michał Bieńkowski, Matthias Preusser
Oct 31, 2015·Neuro-oncology·Edjah K NduomAmy B Heimberger
Oct 21, 2016·Human Gene Therapy·Kara W MoyesCourtney A Crane
Nov 5, 2016·Annual Review of Physiology·Peter J Murray
Nov 12, 2016·Cancer Biology & Therapy·Kristen HaberthurCourtney A Crane
Dec 29, 2016·The New England Journal of Medicine·Christine E BrownBehnam Badie
Aug 16, 2017·Oncoimmunology·Katharina OchsMichael Platten
Dec 6, 2017·The Journal of Experimental Medicine·Zinal S ChhedaHideho Okada
Jan 13, 2018·Expert Review of Neurotherapeutics·Nicole A P LiebermanCourtney A Crane
Feb 20, 2018·Frontiers in Immunology·Nicole A P LiebermanCourtney A Crane
Apr 18, 2018·Nature Medicine·Christopher W MountCrystal L Mackall
Jun 30, 2018·Acta Neuropathologica Communications·Grant L LinMichelle Monje

❮ Previous
Next ❯

Citations

Aug 30, 2019·Current Opinion in Oncology·Razina Aziz-Bose, Michelle Monje
Jul 11, 2019·Current Treatment Options in Neurology·Nicholas A Vitanza, Michelle Monje
Dec 13, 2019·Cancer Metastasis Reviews·Brian HutzenTimothy P Cripe
Jun 17, 2020·Expert Review of Neurotherapeutics·James Felker, Alberto Broniscer
May 18, 2020·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Lei ZhangYunhui Liu
Jul 19, 2019·Journal for Immunotherapy of Cancer·Matthew R SchuelkeRichard G Vile
Feb 8, 2020·Current Oncology Reports·Kyle WierzbickiCarl Koschmann
Oct 3, 2020·International Journal of Molecular Sciences·Maya S Graham, Ingo K Mellinghoff
Jun 17, 2020·The Journal of Clinical Investigation·Rachael L TerryPaul J Neeson
Sep 10, 2020·Frontiers in Oncology·John D PattersonAnaliz Rodriguez
Dec 11, 2020·Brain : a Journal of Neurology·James L RossDolores Hambardzumyan
Nov 24, 2020·Expert Review of Neurotherapeutics·Erin CrottyHideho Okada
Apr 26, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Flor MendezMaria G Castro
Jan 12, 2021·Chinese Neurosurgical Journal·Dilakshan SrikanthanJames T Rutka
Jan 6, 2021·Journal of Neuro-oncology·Brandon WummerCatherine Flores
Feb 10, 2021·Cancer Discovery·James G Nicholson, Howard A Fine
May 2, 2021·NPJ Precision Oncology·Malak AbedalthagafiMusa AlHarbi
Jun 23, 2021·EBioMedicine·Gabrielle PriceConstantinos G Hadjipanayis
Apr 16, 2021·Brain : a Journal of Neurology·James L RossDolores Hambardzumyan
Sep 26, 2021·Cancer Research·Troy A McEachron, Lee J Helman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Related Papers

Pediatric Blood & Cancer
Alicia Castañeda HerediaAndres Morales La Madrid
Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery
Rejin KebudiEmin Darendeliler
© 2022 Meta ULC. All rights reserved